Plasma endoglin level was also independently associated with cancer‐specific and overall survival in both pre‐ and postoperative models (all p < 0.05), as well as with recurrence‐free survival (RFS) in the preoperative model (p < 0.001). This evidence concerns the gene ENG and cancer.